Director Strategy and Operations, Oncology Commercial Strategy at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Bachelor’s degree required; MBA or advanced degree preferred
10+ years of experience in commercial strategy, operations, or consulting within the biopharma industry, with a strong focus on oncology
Proven success in leading global strategic initiatives and product launches in oncology
Strong analytical, communication, and project management skills
Experience working in a matrixed, global organization with ability to influence senior stakeholders
Demonstrated agility to navigate and find solutions in complex markets
Experience of change management leading teams through organizational transformation
Ability to provide a strong voice to the team and success in effectively communicating and influencing decisions with senior management and matrix team
Ability to “flex” across different types of cultures, work, complexities, business situations and matrix partners
Demonstrated ability to successfully and effectively collaborate and work across boundaries (e.g. R&D, disease mgt., marketing, external development) and building strong external relationships
Preferred: Deep understanding of oncology market dynamics, including immuno-oncology, hematology, and precision medicine
Preferred: Familiarity with BMS’s oncology portfolio and pipeline is a plus
Preferred: Experience with digital strategy, omnichannel engagement, and data-driven decision-making

Responsibilities

Lead development of global commercial strategies for key oncology brands and assets in collaboration with Worldwide Brand Teams, Medical, Market Access, and regional partners
Support long-range planning, portfolio strategy, and lifecycle management across solid tumors and hematologic malignancies
Provide strategic insights on competitive landscape, market evolution, and innovation trends (e.g., IO, CELMoDs, bispecifics)
Drive launch readiness and execution for new oncology indications and assets, ensuring alignment across global and regional teams
Develop and manage commercial performance frameworks, including KPIs, dashboards, and business reviews
Optimize commercial processes and governance to enhance agility and decision-making
Partner with Finance, Medical, Regulatory, and Supply Chain to ensure integrated planning and execution
Facilitate strategic forums and governance processes to align stakeholders and drive accountability
Act as a key interface between US Commercial and Global Oncology teams to ensure strategic consistency and local relevance
Lead a team of strategy and operations professionals, fostering a culture of innovation, collaboration, and continuous improvement
Mentor and develop talent, promoting cross-functional exposure and strategic thinking

Skills

Strategic Planning

Commercial Strategy

Oncology

Lifecycle Management

Launch Readiness

KPIs

Dashboards

Business Reviews

Cross-Functional Collaboration

Competitive Analysis

Portfolio Strategy

Market Access

Governance

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free